Your browser doesn't support javascript.
loading
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.
Siegel, Robert D; LeFebvre, Kristine B; Temin, Sarah; Evers, Amy; Barbarotta, Lisa; Bowman, Ronda M; Chan, Alexandre; Dougherty, David W; Ganio, Michael; Mulvey, Therese Marie; Ouzts, Amanda; Polovich, Martha; Salazar-Abshire, Maritza; Stenstrup, Elaine; Sydenstricker, Christine Marie; Tsai, Susan; Olsen, MiKaela.
Afiliación
  • Siegel RD; Bon Secours St Francis Cancer Center.
  • LeFebvre KB; Oncology Nursing Society.
  • Temin S; American Society of Clinical Oncology.
  • Evers A; University of Pennsylvania Health System.
  • Barbarotta L; Smilow Cancer Hospital and Yale Cancer Center.
  • Chan A; University of California, Irvine.
  • Dougherty DW; Wilmot Cancer Institute.
  • Ganio M; American Society of Health-System Pharmacists.
  • Mulvey TM; Massachusetts General Cancer Center.
  • Ouzts A; Huntsville Hospital.
  • Polovich M; Georgia State University.
  • Salazar-Abshire M; The University of Texas MD Anderson Cancer Center.
  • Stenstrup Z; City of Hope National Medical Center
  • Sydenstricker CM; Hondros College of Nursing.
  • Tsai S; Ohio State University Comprehensive Cancer Center.
  • Olsen M; Johns Hopkins Hospital and Health System
Oncol Nurs Forum ; 51(4): 297-320, 2024 06 14.
Article en En | MEDLINE | ID: mdl-38950089
ABSTRACT

PURPOSE:

To update the American Society of Clinical Oncology (ASCO)-Oncology Nursing Society (ONS) standards for antineoplastic therapy administration safety in adult and pediatric oncology and highlight current standards for antineoplastic therapy for adult and pediatric populations with various routes of administration and location.

METHODS:

ASCO and ONS convened a multidisciplinary Expert Panel with representation of multiple organizations to conduct literature reviews and add to the standards as needed. The evidence base was combined with the opinion of the ASCO-ONS Expert Panel to develop antineoplastic safety standards and guidance. Public comments were solicited and considered in preparation of the final manuscript.

RESULTS:

The standards presented here include clarification and expansion of existing standards to include home administration and other changes in processes of ordering, preparing, and administering antineoplastic therapy; the advent of immune effector cellular therapy; the importance of social determinants of health; fertility preservation; and pregnancy avoidance. In addition, the standards have added a fourth verification. STANDARDS Standards are provided for which health care organizations and those involved in all aspects of patient care can safely deliver antineoplastic therapy, increase the quality of care, and reduce medical errors.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermería Oncológica / Seguridad del Paciente / Neoplasias / Antineoplásicos Límite: Adult / Child / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Oncol Nurs Forum Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermería Oncológica / Seguridad del Paciente / Neoplasias / Antineoplásicos Límite: Adult / Child / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Oncol Nurs Forum Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos